SGCG and Bruton-type agammaglobulinemia: Since type I and III IFN offers some protection against CNS invasion by maintaining the integrity of blood–brain barrier (82), the integrity of blood–brain barrier in XLA patients may be compromised, becoming more vulnerable to neuroinvasion.